GW PHARMACEUTICALS PLC — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7b6aaf16-c04c-4d33-b63a-9d083faf0ee2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-51.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-009430 |
| FY 2019 | $-118.4M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-007319 |
| FY 2018 | $-288.8M | 2017-10-01 – 2018-09-30 | evidence 0001564590-18-030224 |
| FY 2017 | $-166.2M | 2016-10-01 – 2017-09-30 | evidence 0001564590-18-030224 |
| FY 2016 | $-128.7M | 2015-10-01 – 2016-09-30 | evidence 0001564590-18-030224 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).